Dynavax Technologies Corporation
DVAX
$10.76
$0.1351.27%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 307.23M | 285.55M | 268.43M | 248.46M | 231.44M |
| Total Other Revenue | 9.04M | 9.08M | 8.82M | 12.35M | 18.26M |
| Total Revenue | 316.27M | 294.62M | 277.25M | 260.81M | 249.70M |
| Cost of Revenue | 107.60M | 105.60M | 96.85M | 87.47M | 87.39M |
| Gross Profit | 208.67M | 189.02M | 180.40M | 173.34M | 162.30M |
| SG&A Expenses | 187.30M | 178.75M | 168.10M | 168.11M | 163.25M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 308.16M | 295.76M | 276.35M | 266.99M | 262.05M |
| Operating Income | 8.11M | -1.14M | 893.00K | -6.18M | -12.36M |
| Income Before Tax | -49.21M | -55.52M | 30.86M | 24.22M | 18.55M |
| Income Tax Expenses | 3.52M | 4.55M | 3.55M | 3.75M | 1.37M |
| Earnings from Continuing Operations | -52.73 | -60.07 | 27.31 | 20.48 | 17.18 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -52.73M | -60.07M | 27.31M | 20.48M | 17.18M |
| EBIT | 8.11M | -1.14M | 893.00K | -6.18M | -12.36M |
| EBITDA | 12.90M | 3.54M | 5.52M | -1.62M | -7.87M |
| EPS Basic | -0.42 | -0.49 | 0.21 | 0.16 | 0.13 |
| Normalized Basic EPS | 0.16 | 0.12 | 0.15 | 0.12 | 0.08 |
| EPS Diluted | -0.46 | -0.52 | 0.18 | 0.13 | 0.11 |
| Normalized Diluted EPS | 0.13 | 0.09 | 0.12 | 0.09 | 0.06 |
| Average Basic Shares Outstanding | 503.27M | 514.87M | 520.20M | 521.63M | 519.49M |
| Average Diluted Shares Outstanding | 571.06M | 587.17M | 592.50M | 572.75M | 572.14M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |